MTHRF

M3, Inc. [MTHRF] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

MTHRF Stock Summary

Earnings have grown 10.89% per last year.

Earnings are expected to fall -100% next year

Unstable dividend track record

MTHRF has less than 1 year of cash runway

An RSI reading of 30 or below indicates an oversold or undervalued condition.

In the News

MTHRF Financial details

Company Rating

Strong Buy

Market Cap

9.91B

Income

46.36B

Revenue

234.85B

Book val./share

496.48

Cash/share

249.83

Dividend

0.14

Dividend %

0.9%

Employees

10.53K

Optionable

Shortable

Yes

Earnings

26 Apr 2024

P/E

32.14

Forward P/E

PEG

-11.73

P/S

6.64

P/B

4.69

P/C

0.06

P/FCF

32.34

Quick Ratio

2.63

Current Ratio

3.56

Debt / Equity

LT Debt / Equity

EPS (TTM)

68.28

EPS next Y

EPS next Q

EPS this Y

-23.22%

EPS next Y

EPS next 5Y

EPS last 5Y

19.03%

Revenue last 5Y

15.34%

Revenue Q/Q

8.55%

EPS Q/Q

20.14%

SMA20

-6.82%

SMA50

8.41%

SMA100

Inst Own

Inst Trans

ROA

10%

ROE

16%

ROC

0.18%

Gross Margin

59%

Oper. Margin

30%

Profit Margin

21%

Payout

27%

Shs Outstand

Shs Float

Target Price

52W Range

13.55-24.75

52W High

-39.17%

52W Low

+12.31%

RSI

27.73

Rel Volume

0.25

Avg Volume

406

Volume

100

Perf Week

-17.28%

Perf Month

-14.17%

Perf Quarter

Perf Half Y

-17.75%

Beta

0.744

Volatility

1.74%, 1.16%

Prev Close

1.18%

Price

14.6

Change

1.18%

MTHRF Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	174.52	193.05	249.31	306.67	339.99
Net income per share	30.22	31.89	55.73	94.06	72.22
Operating cash flow per share	27.4	39.49	68.7	76.77	84.13
Free cash flow per share	25.32	35.3	65.77	72.03	72.97
Cash per share	47.15	121.77	170.04	208.05	215.63
Book value per share	152.41	244.84	294.42	379.86	445.77
Tangible book value per share	70.1	147.75	193.6	266.73	290.86
Share holders equity per share	152.41	244.84	294.42	379.86	445.77
Interest debt per share	-7.64	3.83	5.47	4.39	4.92
Market cap	1175.7B	2008.04B	5138.54B	3080.05B	2175.72B
Enterprise value	1148.17B	1966.19B	5058.41B	2984.09B	2067.78B
P/E ratio	60.06	92.81	135.86	48.24	44.38
Price to sales ratio	10.4	15.33	30.37	14.8	9.43
POCF ratio	66.24	74.96	110.21	59.11	38.09
PFCF ratio	71.67	83.85	115.12	63	43.92
P/B Ratio	11.91	12.09	25.72	11.95	7.19
PTB ratio	11.91	12.09	25.72	11.95	7.19
EV to sales	10.16	15.01	29.9	14.34	8.96
Enterprise value over EBITDA	35.52	50.23	78.9	32.06	25.27
EV to operating cash flow	64.69	73.4	108.49	57.27	36.21
EV to free cash flow	69.99	82.1	113.32	61.04	41.74
Earnings yield	0.02	0.01	0.01	0.02	0.02
Free cash flow yield	0.01	0.01	0.01	0.02	0.02
Debt to equity	-0.05	0.02	0.02	0.01	0.01
Debt to assets	-0.04	0.01	0.01	0.01	0.01
Net debt to EBITDA	-0.85	-1.07	-1.25	-1.03	-1.32
Current ratio	2.29	3.19	3.26	3.48	3.42
Interest coverage	2.57K	880.44	522.27	1.83K	1.04K
Income quality	0.57	0.77	0.8	0.54	0.77
Dividend Yield	0	0	0	0	0
Payout ratio	0.17	0.21	0.15	0.13	0.22
Sales general and administrative to revenue	0.32	0.3	0.27	0.27	0.28
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.41	0.32	0.28	0.24	0.28
Capex to operating cash flow	-0.08	-0.11	-0.04	-0.06	-0.13
Capex to revenue	-0.01	-0.02	-0.01	-0.02	-0.03
Capex to depreciation	-0.97	-0.63	-0.35	-0.51	-1.02
Stock based compensation to revenue	0	0	0	0	0
Graham number	321.92	419.13	607.6	896.62	851.08
ROIC	0.23	0.14	0.2	0.25	0.16
Return on tangible assets	0.24	0.14	0.19	0.24	0.17
Graham Net	27.01	86.03	123	144.88	138.83
Working capital	35.99B	83.4B	113.8B	141.66B	143.89B
Tangible asset value	45.41B	100.24B	131.39B	181.05B	197.47B
Net current asset value	28.96B	71.31B	98.25B	116.85B	112.34B
Invested capital	-0.05	0.02	0.02	0.01	0.01
Average receivables	14.16B	30.97B	38.89B	47.56B	50.82B
Average payables	13.57B	15.91B	18.93B	24.77B	30.92B
Average inventory	751M	1.53B	1.6B	1.75B	1.91B
Days sales outstanding	91.41	93.68	95.25	89.38	80.13
Days payables outstanding	107.65	108.68	114.04	124.59	125.43
Days of inventory on hand	11.14	9.78	9.16	7.94	7.54
Receivables turnover	3.99	3.9	3.83	4.08	4.56
Payables turnover	3.39	3.36	3.2	2.93	2.91
Inventory turnover	32.77	37.31	39.83	45.99	48.42
ROE	0.2	0.13	0.19	0.25	0.16
Capex per share	-2.08	-4.19	-2.93	-4.74	-11.16

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	92.12	81.99	84.54	86.02	93.37
Net income per share	22.42	14.36	18.28	16.19	19.45
Operating cash flow per share	12.04	34.95	17.62	21.89	12.95
Free cash flow per share	9.85	29.38	12.7	18.88	9.85
Cash per share	198.43	215.62	238.73	247.73	249.83
Book value per share	428.26	445.75	466.65	488.44	496.48
Tangible book value per share	283.56	290.85	308.03	304.2	313.96
Share holders equity per share	428.26	445.75	466.65	488.44	496.48
Interest debt per share	0.38	4.85	0.1	0.14	0.59
Market cap	2447.27B	2175.81B	2319.74B	1900.52B	1422.16B
Enterprise value	2345.86B	2067.87B	2217.92B	1794.18B	1310.04B
P/E ratio	40.2	55.8	46.72	43.23	26.92
Price to sales ratio	39.13	39.09	40.42	32.54	22.43
POCF ratio	299.47	91.71	193.93	127.9	161.74
PFCF ratio	365.81	109.07	269.14	148.29	212.58
P/B Ratio	8.42	7.19	7.32	5.73	4.22
PTB ratio	8.42	7.19	7.32	5.73	4.22
EV to sales	37.51	37.15	38.64	30.72	20.67
Enterprise value over EBITDA	96.57	127.75	101.36	90.69	57.78
EV to operating cash flow	287.06	87.16	185.41	120.75	148.99
EV to free cash flow	350.65	103.66	257.33	140	195.82
Earnings yield	0.01	0	0.01	0.01	0.01
Free cash flow yield	0	0.01	0	0.01	0
Debt to equity	0	0.01	0	0	0
Debt to assets	0	0.01	0	0	0
Net debt to EBITDA	-4.17	-6.67	-4.65	-5.38	-4.95
Current ratio	3.66	3.42	3.85	3.56	3.95
Interest coverage	86.64	576.04	276.98	179.95	50.88
Income quality	0.37	1.69	0.6	0.85	0.44
Dividend Yield	0	0	0.01	0	0
Payout ratio	0	0	0.97	0.08	0
Sales general and administrative to revenue	0.26	0.32	0.31	0.32	0.29
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.28	0.28	0.27	0.3	0.3
Capex to operating cash flow	-0.18	-0.16	-0.28	-0.14	-0.24
Capex to revenue	-0.02	-0.07	-0.06	-0.03	-0.03
Capex to depreciation	-0.8	-1.8	-1.68	-0.93	-0.93
Stock based compensation to revenue	0	0	0	0	0
Graham number	464.77	379.5	438.16	421.81	466.16
ROIC	0.05	0.03	0.04	0.03	0.04
Return on tangible assets	0.06	0.03	0.04	0.03	0.04
Graham Net	137.28	138.83	129.32	135.09	143.54
Working capital	143.56B	143.89B	169.34B	163.43B	172.76B
Tangible asset value	192.51B	197.47B	209.13B	206.54B	213.17B
Net current asset value	114.08B	112.34B	117.94B	111.52B	118.56B
Invested capital	0	0.01	0	0	0
Average receivables	52.53B	53.24B	49.72B	50.63B	53.28B
Average payables	30.6B	31.91B	33.3B	34.87B	35.54B
Average inventory	0	987.5M	987.5M	0	0
Days sales outstanding	80.31	81.93	76.48	80.9	76.75
Days payables outstanding	112.29	126.2	133.41	133.86	124.52
Days of inventory on hand	0	7.58	0	0	0
Receivables turnover	1.12	1.1	1.18	1.11	1.17
Payables turnover	0.8	0.71	0.67	0.67	0.72
Inventory turnover	0	11.87	0	0	0
ROE	0.05	0.03	0.04	0.03	0.04
Capex per share	-2.18	-5.56	-4.92	-3.01	-3.1

MTHRF Dividend History

MTHRF Frequently Asked Questions

What is M3, Inc. stock symbol ?

M3, Inc. is a JP stock and trading under the symbol MTHRF

What is M3, Inc. stock quote today ?

M3, Inc. stock price is $14.6 today.

Is M3, Inc. stock public?

Yes, M3, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 406
Market Capitalization 9.91B
Employee 10.53K
CEO Mr. Itaru Tanimura
Headquarters Tokyo,JP
IPO Date 2014-09-09
Website https://corporate.m3.com

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.